Brain News and Research

RSS
Ambit commences Phase I advanced solid tumor trials for AC430 and AC480 inhibitors

Ambit commences Phase I advanced solid tumor trials for AC430 and AC480 inhibitors

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

VistaGen reports successful completion of AV-101 Phase 1 safety study for neuropathic pain

Lilly completes acquisition of Avid

Lilly completes acquisition of Avid

Proteins that unlock the mystery of over 100 brain diseases

Proteins that unlock the mystery of over 100 brain diseases

Mind Technologies to sell Emotiv EEG headset

Mind Technologies to sell Emotiv EEG headset

OXIS International files patent application to strengthen Ergothioneine intellectual property portfolio

OXIS International files patent application to strengthen Ergothioneine intellectual property portfolio

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Arrowhead launches new company, Ablaris to commercialize novel weight loss technology

Natus Medical anticipates revenue of $247M to $250M for full year 2011

Natus Medical anticipates revenue of $247M to $250M for full year 2011

Exciting progress made in MS research during 2010

Exciting progress made in MS research during 2010

Improved brain-machine technologies

Improved brain-machine technologies

Nose job gone horribly wrong

Nose job gone horribly wrong

Completely fearless woman stirs scientific interest

Completely fearless woman stirs scientific interest

Tips to enjoy holiday food and other special parts of the season

Tips to enjoy holiday food and other special parts of the season

Early intervention can improve core symptoms of ASD in young children: Study

Early intervention can improve core symptoms of ASD in young children: Study

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

Elsevier Foundation's new library grants focus on telemedicine, HIV/AIDS videos and Egyptian cancer database

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

Diagenic, Pfizer enter collaboration to identify biomarkers in early stages of Alzheimer's disease

Study highlights death or rehospitalization rates for Medicare beneficiaries with ischemic stroke

Study highlights death or rehospitalization rates for Medicare beneficiaries with ischemic stroke

Ischemic stroke patients at substantial risk once leaving the hospital: Study

Ischemic stroke patients at substantial risk once leaving the hospital: Study

Alzheimer's Association applauds Congress for passage of NAPA Bill

Alzheimer's Association applauds Congress for passage of NAPA Bill

Researchers contribute important expertise to new landmark study of medulloblastoma

Researchers contribute important expertise to new landmark study of medulloblastoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.